Skip to content

CROI: Saquinavir-based combination prevents mother-to-child HIV transmission

CROI: Simplified treatment regimens show promise in HIV-infected children

Could interactions with other antiretrovirals cause ‘tenofovir-associated’ kidney disease?

ICAAC: Dividing Triomune tablets may result in inadequate doses for small children; liquid best

ICAAC: Achillion reveals potential for once weekly dosing of nucleoside analogue

ICAAC: Nevirapine and rifampicin can be safely used together

Are atazanavir levels reduced by antacids?

Rifabutin dose must be increased in patients taking efavirenz

Efavirenz may linger for up to eight weeks after treatment stops